Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment

Area of Science:

• Materials Science
• Oncology
• Nanotechnology

Background:

• Osteosarcoma (OS) is a primary bone cancer in children and adolescents with limited treatment progress.
• Current treatments (surgery, chemotherapy, radiotherapy) are insufficient for metastatic or recurrent OS.
• Immunotherapies show potential but face challenges due to OS's low immunogenicity and immunosuppressive microenvironment.

Purpose of the Study:

• To systematically review nanomaterial applications in osteosarcoma (OS) therapy.
• To analyze mechanism-specific interventions and recent advancements in nanomedicine for OS.
• To evaluate strategies for enhancing therapeutic efficacy and reducing toxicity in OS treatment.

Main Methods:

• Materials science perspective on nanomaterial interventions for OS.
• Analysis of advancements in OS nanotherapeutics over the past five years.
• Critical evaluation of current strategies for optimizing OS treatment efficacy and safety.

Main Results:

• Nanomedicine presents promising solutions for optimizing osteosarcoma (OS) treatment.
• Recent advancements focus on enhancing therapeutic efficacy and reducing toxicity profiles.
• Systematic examination of mechanism-specific nanomaterial interventions in OS therapy.

Conclusions:

• Nanomedicine offers a promising avenue for improving osteosarcoma (OS) treatment outcomes.
• Further research and development are needed to overcome challenges in clinical translation of nanotherapeutics.
• A framework for next-generation nanotherapeutic platforms is proposed to address persistent limitations in OS management.